High-potency Class I to II topicals are frequently used first line to suppress inflammation and symptoms of itching. These agents are often useful as therapy for stage IA disease, but are often ...

The following is a summary of “ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome,” published in the April 2025 issue of ...

Get Instant Summarized Text (Gist) Pulmonary artery denervation (PADN) shows promise as an intervention for pulmonary hypertension, improving key hemodynamic parameters and clinical outcomes. A ...

Get Instant Summarized Text (Gist) Sotatercept, a novel drug administered via subcutaneous injection, has shown significant efficacy in treating advanced pulmonary arterial hypertension (PAH), a ...

State Key Laboratory of Environmental and Biological Analysis, Department of Chemistry, Hong Kong Baptist University, Hong Kong 999077, China ...

CHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk patients helped delay serious outcomes in the ZENITH trial. Among 172 ...

MDCT and 3D evaluation of type 2 hypoplastic pulmonary artery sling associated with right lung agenesis, hypoplastic aortic arch, and long segment tracheal stenosis.